This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This DLEC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 263-292 amino acids from the N-terminal region of human DLEC1.
DLEC1
Reactivité: Humain
ELISA, WB
Hôte: Lapin
Polyclonal
FITC
Indications d'application
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
DLEC1
(Deleted in Lung and Esophageal Cancer 1 (DLEC1))
anticorps DLC1, anticorps F56, anticorps D630005C06Rik, anticorps deleted in lung and esophageal cancer 1, anticorps deleted in lung and esophageal cancer protein 1, anticorps DLEC1, anticorps LOC100187070, anticorps Dlec1
Sujet
This gene contains 37 exons, spans approximately 59-kb, and is located in the 3p22-p21.3 chromosomal segment that is commonly deleted in various carcinomas. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins. Aberrant transcription of this gene may be involved in carcinogenesis of the lung, esophagus, and kidney.